InGeno is a biomedically focused startup with the slogan "Know Your Uniqueness". Founded in 2021 in Italy, it has positioned itself as a collaboration between professionals, doctors, and researchers in the DNA diagnostic and therapeutic field. Their strong belief in innovation has led to the creation of diagnostic and therapeutic solutions that are personalized based on a person's unique DNA characteristics, aiming to effectively meet the needs of their clients. The latest milestone for InGeno was the €110.00K Pre Seed Round investment on 03 February 2023, which came from VITA Accelerator. This demonstrates a promising potential for growth and development, as well as the recognition of their innovative approach by investors.
No recent news or press coverage available for InGeno.